AZN•benzinga•
Beyfortus Output Tripled As Sanofi, AstraZeneca Scale Up For RSV Season
Summary
Sanofi boosts Beyfortus output for RSV season while Dupixent trial shows strong eczema relief in patients with skin of color.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 9, 2025 by benzinga